Indicators

Latest News about BBIO

Recent news which mentions BBIO

< Previous 1 2 3 4 5 Next >

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday

July 27, 2022

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

July 26, 2022

BridgeBio Pharma Touts Encouraging Data From Dwarfism Candidate

July 26, 2022

BridgeBio Pharma Posts Promising Data From Gene Therapy Trial In Ultra-Rare Disease

June 22, 2022

BridgeBio Pharma Reveals Early Positive Data For Canavan Disease

June 22, 2022

89 Biggest Movers From Friday

June 21, 2022

BridgeBio Pharma's Return On Capital Employed Insights

May 31, 2022

BridgeBio Pharma Posts Early Data From Neurological Movement Disorder Candidate

May 26, 2022

6 Analysts Have This to Say About BridgeBio Pharma

May 24, 2022

BridgeBio Partnered Protein Replacement Therapy Shows Promising Action In Painful Skin Blistering Disorder

May 20, 2022

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product

May 13, 2022

10 Amazing Stocks Under $10 (Part II)

May 13, 2022

BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology

May 12, 2022

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

May 12, 2022

Where BridgeBio Pharma Stands With Analysts

May 06, 2022

BridgeBio Shares Plunge After it Details Out-Licensing Plans For 'Restructuring Initiative'

May 05, 2022

BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy Trial

April 04, 2022

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data

March 17, 2022

What 6 Analyst Ratings Have To Say About BridgeBio Pharma

March 16, 2022

Where BridgeBio Pharma Stands With Analysts

March 16, 2022

BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market

March 14, 2022

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

March 13, 2022

Sentynl Buys BridgeBio Pharma's Fosdenopterin Rights In Genetic Disorder

March 08, 2022

Helsinn, BridgeBio Pharma Amend Infigratinib Pact For Oncology Indications

March 03, 2022

12 biotech stocks to consider buying now as prospects for the sector brighten this year

February 06, 2022

Insider Weekends: Co-Founder Of EverQuote Acquires $1.45 Million Worth Of Stock

January 09, 2022

3 Can't-Miss Biotech Events Coming Up in 2022

January 07, 2022

BZ Chart Of The Day: BridgeBio Pharma Teaches Traders Harsh Lesson

January 05, 2022

40 Biggest Movers From Friday

January 03, 2022

The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week

January 02, 2022

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.